Current Perspectives regarding Stem Cell-Based Therapy for Alzheimer’s Disease
Alzheimer’s disease (AD), a progressive neurodegenerative disorder featuring memory loss and cognitive impairment, is caused by synaptic failure and the excessive accumulation of misfolded proteins. Many unsuccessful attempts have been made to develop new small molecules or antibodies to intervene i...
Saved in:
Main Authors: | Kyeong-Ah Kwak, Seung-Pyo Lee, Jin-Young Yang, Young-Seok Park |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2018/6392986 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current Perspectives in Mesenchymal Stem Cell Therapies for Osteoarthritis
by: Baldur Kristjánsson, et al.
Published: (2014-01-01) -
Diagnosis and Treatment of Alzheimer’s Disease: Current Update
by: Younghee Yim, et al.
Published: (2025-01-01) -
Second-generation anti-amyloid monoclonal antibodies for Alzheimer’s disease: current landscape and future perspectives
by: Byeong-Hyeon Kim, et al.
Published: (2025-01-01) -
Exposure of Mesenchymal Stem Cells to an Alzheimer’s Disease Environment Enhances Therapeutic Effects
by: Sang Eon Park, et al.
Published: (2021-01-01) -
Modeling Alzheimer’s Disease with Induced Pluripotent Stem Cells: Current Challenges and Future Concerns
by: Weiwei Zhang, et al.
Published: (2016-01-01)